Diabetes Flashcards
screening, lifestyle, comprehensive care, natural products, tx algorithms, non-insulins, insulin dosing and calc, BG monitoring, hypoglycemia management, acute care DM, key counseling points
risk factors for DM
physical inactivity
BMI >/= 25
race/ethnicity
PMH gestational
a1c >/=5.7
first degree relative
HDL <35, TG >250
BP >140/90
CVD or smoking hx
s/sx diabetes
3 P’s
polyuria
polydipsia
polyphagia
what a1c, FBG and PPG are considered pre-DM
a1c 5.7-6.5
FBG 100-125
PPG 140-199
what a1c, FBG and PPG are considered DM
a1c >/= 6.5
FBG >/= 126
PPG >/= 200
an a1c of 6% = average BG of ______
and an increase of 1% = an increase in average BG of_______________-
126mg/dL
1% : 28mg/dL
lifestyle modifications for DM
weight loss 5% +
carb counting
exercise 150+ min a week
smoking cessation
comprehensive care
microvascular complications
nephropathy
retinopathy
neuropathy
macrovascular complications
ASCVD, MI, CVD
CVA
PAD
ASA recommendation for DM
secondary prevention only, 81mg po qd
how often should patients get an eye exam in DM
q1-2 years
1 year is if they have retinopathy
what vaccines are recommended in DM
HBV
influenza
pneumococcal
how often should DM patients get foot exams
annually
HLD management in DM
which statin? what is the LDL goal?
> 40 yo w ASCVD – > high intensity
no ASCVD or <40 w ASCVD –> mod intensity
goal <55 w ASCVD
goal <70 without ASCVD
how often should eGFR and UAlb be monitored in DM
yearly
what medications are recommended for hyperalbuminuria in DM
ACEi, ARB, SGLT2i, finerenone
BP goal in DM
<130/80
BP management in DM
no albuminuria or CAD: thiazide, ACE, ARB, CCB
albuminuria or CAD: ACEi or ARB
first line for ASCVD or high risk patient (>55 w 2 RFs)
GLP1RA
SGLT2i
first line for HF concern
SGLT2i
first line for CKD concern
= eGFR ____
= Ualb____
eGFR </= 60
UAlb >30
SGLT2i if eGFR >20 then GLP1RA
rybelsus dosing
3mg po qd 30 min before breakfast x30d then increase to 7mg po qd, MDD 14mg
GLP1RAs with cardiorenal benefits
semaglutide SC, liraglutide, dulaglutide
SGLT2i with cardiorenal benefits
dapa empa canag
TZD example
pioglitazone
DPP4-i
drugs in class
-gliptins
GLP1RA are not to be used with ______ due to overlapping MOA
DPP4-i
metformin is titrated every ________
week
metformin should not be started when __________, but is safe to continue until ______
should not be started with eGFR 40-45 but is ok to continue until eGFR of 30
BBW for metformin
lactic acidosis
lactic acidosis due to metformin is at an increased risk with
alcohol consumption
glyburide
brand
dosing
MDD
Glynase
2.5-5mg QD, MDD 30mg
glipizide
brand
dosing
MDD
Glucotrol
5mg QD (MDD 40 for IR, 20 for ER)
doses >_____ must be divided BID with glipizide
15mg
glimepiride
brand
dosing
MDD
Amaryl
1-2mg QD
MDD 8mg
glipizide should be administered
A. with breakfast
B. 30 min before a meal
C. after lunch
D. anytime of day with a glass of water
B. 30 min before a meal
preferably breakfast
sitagliptin
brand
MOA
dosing
Januvia
DPP4-i
100mg PO QD
eGFR <30 –> 25mg PO QD
eGFR 30-45 –> 50mg PO QD
linagliptin
brand
MOA
dosing
Tradjenta
DPP4-i
5mg PO QD
which DPP4-is have a warning for HF
saxogliptin and alogliptin
pioglitazone
dosing
15-30mg PO QD, MDD 45mg
rapid acting insulins
Novolog (aspart)
Admelog (lispro)
short-acting insulins
regular!!
Humulin-R
Novolin-R
intermediate acting insulins
NPH
(Humulin-N)
(Novolin-N)
glargine brand names
Semglee
Lantus
Toujeo
Basaglar
detemir
Levemir
degludec brand
Tresiba
basal insulin dose for patients with T2DM
0.1-0.2 units/kg/day
how do we add on a bolus insulin dose in a T2DM
10% of TDD
how do we initiate insulin in a T1DM
0.5U/kg/day
take 50% as bolus and 50% as basal
how do we calculate ICR for type 1 diabetics
for regular insulin 450/TDD
for rapid insulin 500/TDD
what does an ICR represent
1 unit of insulin will cover X carbs
correction factor calculations
regular insulin 1500/TDD
rapid acting insulin 1800/TDD
humalog expiration date
10 days
novolog exp date
14 days
glargine exp date
28d
regular insulin exp date
28d
levemir exp date
42d
tresiba exp date
56d
toujeo exp date
56d
what drugs dec BG
FQ
BB
tramadol
linezolid
what meds inc BG
steroids
FQ
APs
BB
thiazides
loops
tacro
CYA
protease-i
inpatient BG goals
140-180mg/dL
DKA vs HHS
DKA: BG >250, ketones, HAGMA, pH <7.35
HHS: BG >600, pH>7.3, osmolality >320
DKA/HHS treatment
fluids (NS then D5W1/2NS once BG <200)
regular insulin 0.1U/kg bolus then 0.1U/kg/hr OR 0.14 U/kg/hr
bicarb if acidotic
K if needed